Cardiovascular Toxicology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.3 | Q2 | 66.2% | 0.903 | Q2 | 81.1% |
| 2024 | 3.7 | Q1 | 76.5% | 0.834 | Q2 | 79.2% |
| 2023 | 3.4 | Q2 | 68.9% | 0.757 | Q2 | 78.1% |
| 2022 | 3.2 | Q2 | 56.1% | 0.666 | Q2 | 75.3% |
| 2021 | 2.8 | Q3 | 34.0% | 0.562 | Q2 | 70.8% |
| 2020 | — | — | 0.723 | Q2 | 77.0% | |
| 2019 | — | — | 0.706 | Q2 | 77.1% | |
| 2018 | — | — | 0.837 | Q2 | 79.7% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1559-0259
ISSN
1530-7905
region
Northern America
coverage
2001-2026